Jordan

Jordan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.37 (3.26 - 3.48) 2019 Modelled IHME
3.41 (3.30 - 3.51) 2018 Modelled IHME
3.48 (3.36 - 3.59) 2017 Modelled IHME
3.61 (3.50 - 3.71) 2016 Modelled IHME
3.77 (3.65 - 3.89) 2015 Modelled IHME
3.92 (3.81 - 4.04) 2014 Modelled IHME
4.07 (3.96 - 4.20) 2013 Modelled IHME
4.23 (4.11 - 4.35) 2012 Modelled IHME
4.39 (4.26 - 4.52) 2011 Modelled IHME
4.57 (4.43 - 4.71) 2010 Modelled IHME
4.78 (4.63 - 4.92) 2009 Modelled IHME
5 (4.85 - 5.14) 2008 Modelled IHME
5.24 (5.08 - 5.38) 2007 Modelled IHME
5.48 (5.31 - 5.63) 2006 Modelled IHME
5.72 (5.54 - 5.88) 2005 Modelled IHME
5.95 (5.77 - 6.11) 2004 Modelled IHME
6.18 (6.01 - 6.34) 2003 Modelled IHME
6.42 (6.23 - 6.58) 2002 Modelled IHME
6.66 (6.47 - 6.83) 2001 Modelled IHME
6.9 (6.68 - 7.08) 2000 Modelled IHME
7.16 (6.94 - 7.35) 1999 Modelled IHME
7.44 (7.19 - 7.63) 1998 Modelled IHME
7.71 (7.44 - 7.91) 1997 Modelled IHME
7.97 (7.67 - 8.19) 1996 Modelled IHME
8.2 (7.85 - 8.43) 1995 Modelled IHME
8.4 (8.07 - 8.62) 1994 Modelled IHME
8.58 (8.27 - 8.81) 1993 Modelled IHME
8.76 (8.44 - 8.99) 1992 Modelled IHME
8.91 (8.58 - 9.14) 1991 Modelled IHME
9.04 (8.72 - 9.28) 1990 Modelled IHME
2.59 (1.64 - 3.86) 2015 Modelled WHO
2.4 (1.30 - 2.80) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.53 (0.50 - 0.56) 2019 Modelled IHME
0.57 (0.54 - 0.61) 2018 Modelled IHME
0.59 (0.55 - 0.63) 2017 Modelled IHME
0.59 (0.55 - 0.62) 2016 Modelled IHME
0.58 (0.54 - 0.62) 2015 Modelled IHME
0.54 (0.51 - 0.58) 2014 Modelled IHME
0.48 (0.45 - 0.51) 2013 Modelled IHME
0.41 (0.39 - 0.44) 2012 Modelled IHME
0.35 (0.33 - 0.38) 2011 Modelled IHME
0.33 (0.31 - 0.35) 2010 Modelled IHME
0.33 (0.31 - 0.35) 2009 Modelled IHME
0.33 (0.31 - 0.35) 2008 Modelled IHME
0.33 (0.31 - 0.35) 2007 Modelled IHME
0.33 (0.31 - 0.35) 2006 Modelled IHME
0.33 (0.31 - 0.36) 2005 Modelled IHME
0.34 (0.32 - 0.36) 2004 Modelled IHME
0.36 (0.34 - 0.38) 2003 Modelled IHME
0.39 (0.37 - 0.41) 2002 Modelled IHME
0.43 (0.40 - 0.45) 2001 Modelled IHME
0.48 (0.45 - 0.51) 2000 Modelled IHME
0.81 (0.76 - 0.86) 1999 Modelled IHME
1.56 (1.45 - 1.66) 1998 Modelled IHME
2.48 (2.31 - 2.66) 1997 Modelled IHME
3.37 (3.12 - 3.62) 1996 Modelled IHME
4 (3.70 - 4.31) 1995 Modelled IHME
4.41 (4.09 - 4.74) 1994 Modelled IHME
4.78 (4.46 - 5.13) 1993 Modelled IHME
5.1 (4.77 - 5.49) 1992 Modelled IHME
5.34 (5 - 5.76) 1991 Modelled IHME
5.49 (5.15 - 5.93) 1990 Modelled IHME
1.01 (0.55 - 1.73) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
341,235 (329,149 - 350,311) 1990 Modelled IHME
348,678 (335,913 - 357,834) 1991 Modelled IHME
354,192 (341,564 - 363,644) 1992 Modelled IHME
357,643 (344,767 - 367,161) 1993 Modelled IHME
358,888 (345,072 - 368,587) 1994 Modelled IHME
357,845 (342,722 - 367,856) 1995 Modelled IHME
354,203 (340,667 - 363,733) 1996 Modelled IHME
348,115 (335,732 - 357,125) 1997 Modelled IHME
340,808 (329,467 - 349,562) 1998 Modelled IHME
333,281 (323,110 - 341,917) 1999 Modelled IHME
326,296 (316,037 - 334,786) 2000 Modelled IHME
320,356 (311,217 - 328,587) 2001 Modelled IHME
315,499 (306,457 - 323,254) 2002 Modelled IHME
311,770 (302,958 - 319,648) 2003 Modelled IHME
316,467 (306,701 - 324,983) 2004 Modelled IHME
328,996 (318,637 - 338,160) 2005 Modelled IHME
334,665 (324,279 - 343,817) 2006 Modelled IHME
333,150 (323,291 - 342,397) 2007 Modelled IHME
331,868 (322,198 - 341,022) 2008 Modelled IHME
332,231 (322,007 - 342,093) 2009 Modelled IHME
332,943 (322,299 - 343,045) 2010 Modelled IHME
337,040 (326,699 - 347,064) 2011 Modelled IHME
347,329 (337,274 - 357,654) 2012 Modelled IHME
356,435 (346,088 - 367,097) 2013 Modelled IHME
361,857 (350,974 - 372,925) 2014 Modelled IHME
366,231 (354,431 - 377,802) 2015 Modelled IHME
367,646 (356,342 - 378,423) 2016 Modelled IHME
371,481 (358,496 - 383,594) 2017 Modelled IHME
380,291 (368,000 - 391,733) 2018 Modelled IHME
392,455 (379,237 - 405,060) 2019 Modelled IHME
230,000 (124,000 - 261,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.42 (1.04 - 1.87) 2019 Modelled IHME
1.38 (1.01 - 1.82) 2018 Modelled IHME
1.33 (0.98 - 1.75) 2017 Modelled IHME
1.3 (0.96 - 1.69) 2016 Modelled IHME
1.26 (0.94 - 1.64) 2015 Modelled IHME
1.23 (0.93 - 1.60) 2014 Modelled IHME
1.21 (0.93 - 1.55) 2013 Modelled IHME
1.24 (0.96 - 1.57) 2012 Modelled IHME
1.27 (0.99 - 1.61) 2011 Modelled IHME
1.3 (1.01 - 1.63) 2010 Modelled IHME
1.37 (1.06 - 1.73) 2009 Modelled IHME
1.51 (1.16 - 1.90) 2008 Modelled IHME
1.71 (1.31 - 2.16) 2007 Modelled IHME
1.93 (1.48 - 2.47) 2006 Modelled IHME
2.08 (1.59 - 2.64) 2005 Modelled IHME
2.2 (1.68 - 2.80) 2004 Modelled IHME
2.28 (1.72 - 2.94) 2003 Modelled IHME
2.35 (1.76 - 3.11) 2002 Modelled IHME
2.39 (1.77 - 3.20) 2001 Modelled IHME
2.42 (1.77 - 3.23) 2000 Modelled IHME
2.47 (1.79 - 3.32) 1999 Modelled IHME
2.48 (1.81 - 3.32) 1998 Modelled IHME
2.49 (1.80 - 3.38) 1997 Modelled IHME
2.51 (1.83 - 3.37) 1996 Modelled IHME
2.52 (1.87 - 3.38) 1995 Modelled IHME
2.53 (1.89 - 3.36) 1994 Modelled IHME
2.54 (1.93 - 3.34) 1993 Modelled IHME
2.53 (1.91 - 3.30) 1992 Modelled IHME
2.58 (1.94 - 3.40) 1991 Modelled IHME
2.64 (2 - 3.45) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
166 (121 - 217) 2019 Modelled IHME
154 (112 - 203) 2018 Modelled IHME
143 (105 - 187) 2017 Modelled IHME
132 (98 - 173) 2016 Modelled IHME
122 (91 - 159) 2015 Modelled IHME
114 (86 - 147) 2014 Modelled IHME
106 (81 - 136) 2013 Modelled IHME
102 (79 - 129) 2012 Modelled IHME
98 (76 - 124) 2011 Modelled IHME
95 (74 - 119) 2010 Modelled IHME
95 (74 - 120) 2009 Modelled IHME
100 (77 - 126) 2008 Modelled IHME
109 (83 - 137) 2007 Modelled IHME
118 (90 - 151) 2006 Modelled IHME
120 (91 - 152) 2005 Modelled IHME
117 (89 - 149) 2004 Modelled IHME
115 (87 - 148) 2003 Modelled IHME
116 (86 - 153) 2002 Modelled IHME
115 (85 - 154) 2001 Modelled IHME
114 (84 - 153) 2000 Modelled IHME
115 (83 - 154) 1999 Modelled IHME
113 (83 - 152) 1998 Modelled IHME
112 (81 - 152) 1997 Modelled IHME
112 (81 - 150) 1996 Modelled IHME
110 (82 - 147) 1995 Modelled IHME
108 (81 - 144) 1994 Modelled IHME
106 (81 - 139) 1993 Modelled IHME
102 (77 - 134) 1992 Modelled IHME
101 (76 - 133) 1991 Modelled IHME
100 (75 - 130) 1990 Modelled IHME
419 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
37 (29 - 47) 2019 Modelled IHME
37 (29 - 47) 2018 Modelled IHME
37 (29 - 47) 2017 Modelled IHME
37 (28 - 47) 2016 Modelled IHME
36 (28 - 47) 2015 Modelled IHME
36 (28 - 47) 2014 Modelled IHME
36 (28 - 47) 2013 Modelled IHME
36 (28 - 47) 2012 Modelled IHME
36 (28 - 47) 2011 Modelled IHME
36 (28 - 47) 2010 Modelled IHME
36 (28 - 47) 2009 Modelled IHME
37 (28 - 47) 2008 Modelled IHME
37 (29 - 48) 2007 Modelled IHME
37 (29 - 48) 2006 Modelled IHME
37 (29 - 48) 2005 Modelled IHME
38 (29 - 48) 2004 Modelled IHME
38 (30 - 48) 2003 Modelled IHME
38 (30 - 48) 2002 Modelled IHME
38 (30 - 49) 2001 Modelled IHME
39 (31 - 49) 2000 Modelled IHME
39 (31 - 49) 1999 Modelled IHME
39 (31 - 49) 1998 Modelled IHME
39 (31 - 49) 1997 Modelled IHME
40 (31 - 50) 1996 Modelled IHME
40 (31 - 50) 1995 Modelled IHME
40 (32 - 50) 1994 Modelled IHME
40 (31 - 50) 1993 Modelled IHME
40 (31 - 50) 1992 Modelled IHME
40 (31 - 50) 1991 Modelled IHME
40 (31 - 49) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
96 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
98 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
97 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
95 2004 Survey/reported WHO/UNICEF
97 2003 Survey/reported WHO/UNICEF
95 2002 Survey/reported WHO/UNICEF
97 2001 Survey/reported WHO/UNICEF
93 2000 Survey/reported WHO/UNICEF
92 1999 Survey/reported WHO/UNICEF
91 1998 Survey/reported WHO/UNICEF
90 1997 Survey/reported WHO/UNICEF
85 1996 Survey/reported WHO/UNICEF
54 1995 Survey/reported WHO/UNICEF
89 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2018
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
OST in at least one prison
No
NSP in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.96 (0.78 - 1.19) 2019 Modelled IHME
0.85 (0.69 - 1.04) 2018 Modelled IHME
0.75 (0.61 - 0.92) 2017 Modelled IHME
0.65 (0.53 - 0.80) 2016 Modelled IHME
0.59 (0.48 - 0.74) 2015 Modelled IHME
0.59 (0.48 - 0.73) 2014 Modelled IHME
0.59 (0.48 - 0.74) 2013 Modelled IHME
0.59 (0.48 - 0.73) 2012 Modelled IHME
0.59 (0.48 - 0.74) 2011 Modelled IHME
0.6 (0.48 - 0.74) 2010 Modelled IHME
0.6 (0.48 - 0.74) 2009 Modelled IHME
0.6 (0.48 - 0.75) 2008 Modelled IHME
0.61 (0.49 - 0.76) 2007 Modelled IHME
0.63 (0.50 - 0.77) 2006 Modelled IHME
0.64 (0.51 - 0.79) 2005 Modelled IHME
0.69 (0.55 - 0.86) 2004 Modelled IHME
0.77 (0.62 - 0.96) 2003 Modelled IHME
0.87 (0.70 - 1.08) 2002 Modelled IHME
0.95 (0.77 - 1.17) 2001 Modelled IHME
0.98 (0.79 - 1.21) 2000 Modelled IHME
0.98 (0.79 - 1.21) 1999 Modelled IHME
0.98 (0.79 - 1.21) 1998 Modelled IHME
0.97 (0.78 - 1.21) 1997 Modelled IHME
0.97 (0.78 - 1.21) 1996 Modelled IHME
0.97 (0.77 - 1.20) 1995 Modelled IHME
0.97 (0.78 - 1.20) 1994 Modelled IHME
0.97 (0.78 - 1.20) 1993 Modelled IHME
0.97 (0.78 - 1.20) 1992 Modelled IHME
0.97 (0.78 - 1.20) 1991 Modelled IHME
0.98 (0.78 - 1.21) 1990 Modelled IHME
0.3 (0.10 - 0.40) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
36,868 (29,597 - 45,527) 1990 Modelled IHME
38,068 (30,631 - 47,094) 1991 Modelled IHME
39,223 (31,611 - 48,631) 1992 Modelled IHME
40,309 (32,525 - 50,028) 1993 Modelled IHME
41,299 (33,258 - 51,420) 1994 Modelled IHME
42,164 (33,756 - 52,486) 1995 Modelled IHME
43,001 (34,511 - 53,603) 1996 Modelled IHME
43,876 (35,358 - 54,609) 1997 Modelled IHME
44,783 (36,127 - 55,550) 1998 Modelled IHME
45,684 (36,914 - 56,532) 1999 Modelled IHME
46,501 (37,472 - 57,405) 2000 Modelled IHME
45,729 (36,837 - 56,501) 2001 Modelled IHME
42,767 (34,536 - 53,016) 2002 Modelled IHME
38,929 (31,411 - 48,413) 2003 Modelled IHME
36,465 (29,188 - 45,636) 2004 Modelled IHME
36,820 (29,265 - 45,654) 2005 Modelled IHME
38,205 (30,370 - 47,321) 2006 Modelled IHME
39,047 (31,252 - 48,575) 2007 Modelled IHME
40,155 (32,177 - 49,513) 2008 Modelled IHME
41,671 (33,368 - 51,397) 2009 Modelled IHME
43,395 (34,714 - 53,662) 2010 Modelled IHME
45,625 (36,575 - 56,491) 2011 Modelled IHME
48,762 (39,377 - 60,345) 2012 Modelled IHME
51,877 (41,700 - 64,310) 2013 Modelled IHME
54,643 (44,074 - 67,690) 2014 Modelled IHME
57,507 (46,231 - 71,513) 2015 Modelled IHME
66,153 (53,705 - 81,331) 2016 Modelled IHME
80,153 (65,146 - 98,718) 2017 Modelled IHME
94,678 (77,026 - 116,149) 2018 Modelled IHME
111,707 (90,647 - 138,199) 2019 Modelled IHME
25,000 (11,000 - 29,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.86 (2.19 - 3.65) 2019 Modelled IHME
2.76 (2.14 - 3.49) 2018 Modelled IHME
2.66 (2.06 - 3.35) 2017 Modelled IHME
2.6 (2.02 - 3.23) 2016 Modelled IHME
2.53 (2 - 3.12) 2015 Modelled IHME
2.48 (1.98 - 3.05) 2014 Modelled IHME
2.44 (1.95 - 3) 2013 Modelled IHME
2.5 (2 - 3.04) 2012 Modelled IHME
2.56 (2.04 - 3.10) 2011 Modelled IHME
2.59 (2.08 - 3.13) 2010 Modelled IHME
2.61 (2.11 - 3.15) 2009 Modelled IHME
2.63 (2.12 - 3.20) 2008 Modelled IHME
2.71 (2.17 - 3.33) 2007 Modelled IHME
2.81 (2.21 - 3.52) 2006 Modelled IHME
2.85 (2.25 - 3.55) 2005 Modelled IHME
2.89 (2.26 - 3.61) 2004 Modelled IHME
2.89 (2.23 - 3.67) 2003 Modelled IHME
2.92 (2.22 - 3.79) 2002 Modelled IHME
2.89 (2.18 - 3.80) 2001 Modelled IHME
2.85 (2.13 - 3.79) 2000 Modelled IHME
2.86 (2.13 - 3.84) 1999 Modelled IHME
2.83 (2.06 - 3.80) 1998 Modelled IHME
2.8 (2.01 - 3.73) 1997 Modelled IHME
2.78 (2 - 3.76) 1996 Modelled IHME
2.76 (2.01 - 3.72) 1995 Modelled IHME
2.72 (2.03 - 3.65) 1994 Modelled IHME
2.72 (2.04 - 3.59) 1993 Modelled IHME
2.67 (2.03 - 3.47) 1992 Modelled IHME
2.71 (2.04 - 3.54) 1991 Modelled IHME
2.75 (2.06 - 3.56) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
333 (255 - 425) 2019 Modelled IHME
308 (239 - 390) 2018 Modelled IHME
285 (220 - 358) 2017 Modelled IHME
265 (206 - 330) 2016 Modelled IHME
245 (195 - 303) 2015 Modelled IHME
229 (182 - 281) 2014 Modelled IHME
214 (170 - 262) 2013 Modelled IHME
205 (164 - 249) 2012 Modelled IHME
196 (157 - 238) 2011 Modelled IHME
188 (152 - 228) 2010 Modelled IHME
181 (147 - 219) 2009 Modelled IHME
175 (141 - 212) 2008 Modelled IHME
172 (138 - 212) 2007 Modelled IHME
172 (135 - 215) 2006 Modelled IHME
164 (129 - 204) 2005 Modelled IHME
154 (120 - 192) 2004 Modelled IHME
146 (113 - 185) 2003 Modelled IHME
143 (109 - 186) 2002 Modelled IHME
139 (105 - 183) 2001 Modelled IHME
135 (101 - 179) 2000 Modelled IHME
133 (99 - 179) 1999 Modelled IHME
129 (94 - 174) 1998 Modelled IHME
126 (91 - 168) 1997 Modelled IHME
124 (89 - 167) 1996 Modelled IHME
120 (88 - 162) 1995 Modelled IHME
116 (87 - 156) 1994 Modelled IHME
113 (85 - 150) 1993 Modelled IHME
108 (82 - 140) 1992 Modelled IHME
106 (80 - 138) 1991 Modelled IHME
104 (78 - 134) 1990 Modelled IHME
189 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
32 (23 - 41) 2019 Modelled IHME
32 (23 - 41) 2018 Modelled IHME
32 (23 - 41) 2017 Modelled IHME
32 (23 - 41) 2016 Modelled IHME
32 (23 - 41) 2015 Modelled IHME
32 (23 - 41) 2014 Modelled IHME
32 (23 - 41) 2013 Modelled IHME
33 (23 - 41) 2012 Modelled IHME
33 (23 - 41) 2011 Modelled IHME
33 (23 - 41) 2010 Modelled IHME
33 (23 - 42) 2009 Modelled IHME
32 (23 - 41) 2008 Modelled IHME
32 (23 - 41) 2007 Modelled IHME
32 (23 - 42) 2006 Modelled IHME
33 (23 - 42) 2005 Modelled IHME
32 (23 - 41) 2004 Modelled IHME
32 (23 - 41) 2003 Modelled IHME
32 (23 - 41) 2002 Modelled IHME
32 (23 - 41) 2001 Modelled IHME
32 (23 - 40) 2000 Modelled IHME
32 (23 - 40) 1999 Modelled IHME
32 (22 - 40) 1998 Modelled IHME
32 (22 - 40) 1997 Modelled IHME
31 (22 - 40) 1996 Modelled IHME
31 (22 - 40) 1995 Modelled IHME
31 (22 - 40) 1994 Modelled IHME
31 (22 - 40) 1993 Modelled IHME
31 (22 - 40) 1992 Modelled IHME
32 (22 - 40) 1991 Modelled IHME
32 (23 - 40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2018
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
OST in at least one prison
No
NSP in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
166
2019
(121 - 217)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
333
2019
(255 - 425)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines